Clinical Trials Directory

Trials / Completed

CompletedNCT04219553

Antimicrobial Stewardship in Community Pharmacy

Moving Antimicrobial Stewardship Into Community Pharmacy: A Pre-post Study of Acute Otitis Media Management

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
188 (actual)
Sponsor
University of Toronto · Academic / Other
Sex
All
Age
6 Months – 12 Years
Healthy volunteers
Not accepted

Summary

Acute otitis media (AOM) is the most common indication for antibiotics for Canadian paediatric patients. As the gatekeepers of safe and effective prescription pharmacotherapy, community pharmacists are well positioned to influence and optimize antibiotic use. The purpose of this project is to develop, implement, and evaluate an antimicrobial stewardship program in the community pharmacy setting that aims to optimize antibiotic use for AOM. This nonrandomized pre-post study includes children aged 6 months to 12 years presenting with an antibiotic prescription for AOM at two community pharmacies in Toronto, Ontario. Participants are excluded if they exhibit signs/symptoms of mastoiditis, have an additional indication for systemic antibiotics, or parents/guardians cannot consent in English. The multifaceted AMS intervention includes pharmacist education, a clinical decision support tool, a parent/guardian questionnaire, and individualized monthly audit and feedback with each pharmacist. Prescriptions are reviewed and adapted by the pharmacist to optimize congruence with 2016 Canadian Paediatric Society AOM guidelines. The primary outcome is the percentage change in guideline congruence attributable to pharmacist intervention. This study will provide insight into the opportunities and barriers of developing large-scale antimicrobial stewardship programs for community pharmacies.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAntimicrobial stewardshipThe multifaceted AMS intervention includes pharmacist education, a clinical decision support tool, a parent/guardian questionnaire, and individualized monthly audit and feedback with each pharmacist.
OTHERComparator (no intervention)No active intervention

Timeline

Start date
2017-05-25
Primary completion
2017-11-15
Completion
2017-12-01
First posted
2020-01-07
Last updated
2020-01-07

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT04219553. Inclusion in this directory is not an endorsement.